Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

Weight loss jabs like Ozempic and Wegovy should not be used to get the Instagram perfect body, Wes Streeting said amid a ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

近年来兴起的新型减肥药，例如Ozempic和Wegovy，已经帮助全世界的人们减掉了超过15%的体重，它的作用之夸张，以至于沃尔玛将食品销量的下降归因于这些药物的发明和上市。因此，许多人将这种新一代药物称为社会的“游戏规则改变者”。

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

周三，美银证券调整了对诺和诺德公司（NYSE:NVO）股票的展望，将目标价从之前的166.00美元下调至159.50美元，同时维持对该股票的买入评级。这一调整是因为分析师预计第三季度集团销售额将达到约694亿丹麦克朗，同比增长18%，息税前利润（EBIT）将达到约330亿丹麦克朗，较上年同期增长23%。尽管有这些增长，预测的EBIT比共识预期低约4%。

Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...

A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in U.S. adults by 2030.

诺和诺德与Viatris旗下迈兰制药在一份联合文件中表示，已同意解决与诺和诺德减肥药Ozempic和Wegovy相关的专利纠纷。此前诺和诺德已分别在法院起诉Viatris和其他公司侵犯专利，以阻止拟议的仿制药。诺和诺德发言人当地时间10月7日证实了和解协议。

Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...